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In 1996, the American Academy of Pediatrics (AAP)
recommended targeted tuberculin skin testing (TST) of chil-
dren while discouraging routine TST of children without risk
factors for tuberculosis (TB). Recent studies have provided
evidence in support of the targeted TST and recommenda-
tions that favor risk assessment over universal screening
with TST. While evidence for targeted TB testing exists and
benefits of screening programs are clear, administrative
logistics could be a greater issue. The challenge for public
health and school officials is to develop a screening pro-
gram that avoids stigmatization of the at-risk group. Until
then, pediatric healthcare providers will continue to have a
key role in identifying children at risk for latent TB infection
by using the AAP-endorsed risk-assessment questionnaire
and should screen children with TST only when >1 risk fac-
tor is present. 
I
n the 1960s and 1970s, when tuberculosis (TB) infection
rates in the United States were high, universal screening
for TB was required for all children (1). Between the 1980s
and early 1990s, in response to a new increase in incidence
of TB cases in the United States (2–4), the American
Academy of Pediatrics (AAP) recommended annual tuber-
culin testing for high-risk children such as blacks,
Hispanics, the socioeconomically disadvantaged, and chil-
dren living in neighborhoods where the disease rate was
higher than the national average (5). In 1996, the AAP’s
committee on infectious diseases (6) issued updated guide-
lines that called for targeted tuberculin skin testing (TST)
of children and discouraged universal testing of children
who lack risk factors. More recently, these recommenda-
tions were reiterated by a joint statement of the American
Thoracic Society, the Centers for Disease Control and
Prevention (CDC), and the Infectious Diseases Society of
America (7). We review the rationale and evidence in sup-
port of targeted TST in children and discuss some of the
logistic aspects of instituting targeted screening programs.
Who Is at Risk for TB Infection?
Targeted testing is intended to prevent progression of
TB by identifying persons at risk for TB infection or dis-
ease who would benefit from treatment for latent TB infec-
tion (LTBI). Children at high risk for TB infection include
contacts of persons with active TB; those who are foreign-
born; those who travel to or have household visitors from
a country with a high TB prevalence such as Mexico, the
Philippines, Vietnam, India, and China (8); contacts with
high-risk adults, including those who are homeless, incar-
cerated, infected with HIV, or intravenous drug users; and
those with chronic conditions such as diabetes mellitus,
renal failure, malnutrition, or other immunodeficiencies
(6,7). 
The rationale for targeted TB screening includes some
of the following factors. The positive predictive value of
any test, even one with high sensitivity and specificity, is
extremely low in any population with low prevalence of
the disease in question. Universal testing of such a popula-
tion would lead to a low benefit-to-cost ratio. The sensitiv-
ity and specificity of TST are ≈90%, which results in a
higher positive predictive value in high-prevalence popu-
lations (9). Among children with a 1% rate of TB infection,
the positive predictive value is <10%. Thus, >90% of pos-
itive reactions are false positives (10). Since no test can
distinguish false positives from true positives, all persons
with positive TST results must be evaluated and treated.
Falsely identifying TB in a child creates unnecessary cost
for clinic visits, radiographs, treatment with isoniazid that
has harmful side effects, family testing, and follow-up
appointments. In addition, this false identification may
cause anxiety as the physician and family try to determine
the source of a nonexistent infection and create an ethical
dilemma by labeling a child as infected with TB. 
Benefit of Targeted TST in Children
Previous studies have shown a benefit of the targeted
TST in children (11–13). In a study of 2,169 children who
had mandatory TST because they resided in a high-preva-
lence community, Ozuah et al. (11) found a low rate (0.5%)
of TST reactivity. These findings support the revised AAP
guidelines recommending targeted TST of children at high
risk for TB. Cost-effectiveness of school-based targeted
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United States, as well as in other countries, showed that
targeted screening of schoolchildren was more cost effec-
tive than mass screening (12,13). 
Assessment of Risk Factors for LTBI in Children
Several recent studies have addressed the use of risk
assessment to identify children who are likely to have reac-
tive TST results (14–18). Although these studies assessed
different populations, their findings were similar. Lobato et
al. (14) conducted a case-control study in 953 children (<6
years of age) who had a TST read at public health clinics
in California. Risk factors for a positive TST result (>10
mm) among the study population included >1 week for-
eign travel to a country with a high prevalence of TB with-
in the past 12 months (odds ratio [OR] 3.9, 95%
confidence interval [CI] 1.9–7.9) or a household visitor
from such a country (OR 2.4, 95% CI 1.0–5.5).
Saiman et al. (15) conducted a multicenter, prospective,
matched, case-control study in children (1–5 years of age)
in New York who underwent TST by primary care
providers during routine healthcare visits. Of 288 persons,
96 were cases (defined as persons with a TST result >10
mm and a normal chest radiograph) and 192 were age- and
clinic-matched controls (defined as subjects with a TST
result = 0 mm). This study identified several risk factors
for LTBI in children: contact with an adult with TB (risk
ratio [RR] 61.6, p = 0.0004), foreign birth (RR 9.2,
p<0.0001), foreign travel (RR 7.5, p = 0.0002), or a fami-
ly member with LTBI (RR 15.7, p<0.0001). 
In a similar study, Besser et al. (16) identified risk fac-
tors for LTBI in children (<6 years of age) in San Diego,
California, who received a TST as part of routine well-child
care. Fifty-one persons with a TST result >10 mm and nor-
mal chest radiograph and 72 age-matched controls partici-
pated in the study. In this population, Mycobacterium bovis
bacillus Calmette-Guérin (BCG) immunization (OR 53,
95% CI 13–224), a TST within 12 months (OR 24, 95% CI
1.7–347), or a relative with a positive TST result (OR 4.9,
95% CI 1.4–16.5) were risk factors for LTBI. 
Froehlich et al. (17) conducted a prospective observa-
tional study to determine if a risk-assessment question-
naire could predict a positive TST result in a population of
31,926 children (1–18 years of age) in California. This
study found that BCG immunization (OR 2.3, 95% CI
1.7–3.1), foreign birth (OR 8.6, 95% CI 6.2–12.1), living
outside the United States (OR 2.1, 95% CI 1.5–2.9), Asian
(OR 2.3, 95% CI 1.6–3.3) or Hispanic (OR 1.6, 95% CI
1.1–2.3) ethnicity, or contact with a household member
with LTBI or TB (OR 1.5, 95% CI 1.1–2.0) were inde-
pendent predictors of LTBI. 
Ozuah et al. (18) conducted a prospective criterion
standard study of 2,920 children (1–18 years of age) in the
south Bronx, New York, to determine the sensitivity, speci-
ficity, and predictive validity of the New York City
Department of Health (NYCDOH) risk-assessment ques-
tionnaire for identifying children who should receive a
TST. Questionnaire risk factors for TB infection were con-
tact with a case of TB, foreign birth or travel to a TB-
endemic area, contact with adults at high risk for TB (those
who are infected with HIV, homeless, incarcerated, and
illicit drug users), and HIV infection in a child. Contact
with an adult with TB (OR 91.7, 95% CI 32.3–260.7), for-
eign birth or foreign travel (OR 14.8, 95% CI 6.7–32.7),
and contact with a high-risk adult (OR 6.5, 95% CI
2.4–17.5) were independent risk factors for a positive TST
result. Results for the full NYCDOH questionnaire were
sensitivity 85.2%, specificity 86%, negative predictive
value 99.8%, positive predictive value 5.4%, and OR 35.2
(95% CI 12.1–102.4). The data were interpreted as demon-
strating that the NYCDOH questionnaire was a valid
instrument for identifying children for TST. Children with
>1 identifiable risk factor were 35 times more likely to
have a positive TST result. 
Screening Questionnaire for 
Risk Factors for LTBI
These studies have identified risk factors for LTBI in
children. Based on these factors, a risk-assessment ques-
tionnaire was developed by the pediatric tuberculosis col-
laborative group to facilitate LTBI screening by pediatric
healthcare providers (19). Pediatricians should ask the fol-
lowing questions when screening for risk factors of LTBI
during the child’s annual health maintenance visit (19). 1)
Was your child born outside the United States? 2) Has your
child traveled outside the United States? 3) Has your child
been exposed to anyone with TB? 4) Does your child have
close contact with a person who has had a positive TB skin
test result? 5) Does your child spend time with anyone who
has been in jail or a shelter, uses illegal drugs, or has HIV?
6) Has your child drunk raw milk or eaten unpasteurized
cheese? 7) Does your child have a household member who
was born outside the United States? 8) Does your child
have a household member who has traveled outside the
United States? A child or adolescent should be tested with
TST only if >1 risk factor is present. 
Challenges with Targeted Screening 
and LTBI Treatment Adherence 
Despite the revised AAP recommendations for targeted
TST and evidence for use of risk assessment, putting these
guidelines into practice have presented some challenges.
In 1996, the New York City Health Code was amended to
require TST of only new entrants to secondary schools to
reduce unnecessary screening of primary schoolchildren at
low risk for LTBI. A study by Gounder et al. (20) assessed
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that the proportion of new entrants into New York City’s
primary schools who were tested remained virtually
unchanged after implementation of the health code amend-
ment to discontinue testing of these children. In addition,
older children who were more likely to be born in coun-
tries with high TB incidence and were at risk for LTBI
were not tested. 
Lack of clinician adherence to the LTBI screening
guidelines has been shown in another study. Hsu et al. (21)
found that most adolescents identified by risk-assessment
questionnaire to be at risk for LTBI in 3 Boston schools
were not adequately screened for TB infection. These stud-
ies show the necessity of programs to improve healthcare
provider knowledge and acceptance of targeted TB screen-
ing guidelines. Research studies to assess the effect of such
educational programs for clinicians on the targeted TB
screening outcomes are needed. Future studies should also
be conducted to compare the effectiveness of routine TST
for all new high school entrants versus the use of the risk-
assessment questionnaire in different populations. 
Children diagnosed with LTBI must complete the pre-
scribed regimen of isoniazid to maximize the protective
effects of therapy. However, patient adherence to treatment
for LTBI is low. Prevous studies have assessed different
strategies to improve adherence to LTBI treatment
(22–25). Morisky et al. (22) determined the effects of edu-
cational strategies to improve treatment of LTBI among
adolescents in Los Angeles by randomly assigning them to
a peer-counseling group, a group that received incentives,
a combination of peer counseling and incentives, and a
usual-care group. They found no difference in the rates of
completion of LTBI treatment among the 4 groups. 
Cass et al. (23) evaluated the effectiveness of a behav-
ioral intervention, the Treasure Chest, to increase adher-
ence to LTBI therapy in children. Each person received a
monthly calendar with stickers and instructed to place a
sticker on each day the medication was taken. When the
completed calendar was returned, the child was allowed to
select a toy from the Treasure Chest as a reward. Children
who participated in the Treasure Chest program were 2.4
times more likely to complete therapy than those who did
not. Several studies have also reported a significantly high-
er rate of completion of LTBI treatment among those high
school students receiving directly observed therapy
(24,25). Future studies should evaluate measures of adher-
ence to LTBI therapy and other methods (educational
efforts and various incentives) to improve adherence
among different pediatric age groups and populations.
Logistic Aspects of Targeted Screening Programs
While the evidence for targeted TB testing exists and
benefits of screening programs are clear, administrative
logistics are of greater concern. The challenge for public
health and school officials will be to develop a screening
program that would avoid stigmatization of the at-risk
group. One way to reduce stigmatization of the targeted
group of children is to leave identification and screening of
these children in the hands of their primary care providers.
In New York City, every school year a medical information
form that includes TST results is required for each current-
ly or newly enrolled student (20). This form has recently
been revised to reflect the targeted TB screening guide-
lines; however, not all schools have the updated forms. 
To avoid stigmatization, targeted screening could also
be accomplished by involving community organizations
and local clinics that serve recent immigrants or the home-
less population. For example, using community health
workers who are members of the targeted communities
may help eliminate language and cultural barriers in popu-
lations who are difficult to reach and screen for TB. Future
studies are needed to assess the effectiveness of communi-
ty health workers in improving the targeted screening of
at-risk populations.
Conclusions
Several recent studies have shown the benefit of target-
ed TST and validated the use of risk-assessment question-
naires to identify children at increased risk for acquiring
TB (11–18). These studies provide evidence in support of
the targeted TST and recommendations favoring risk
assessment over universal screening with a TST. Targeted
TST and proper management of children with LTBI are
essential components of the TB-elimination strategy pro-
moted by the United States Public Health Service Advisory
Council on the Elimination of Tuberculosis (26). Although
targeted screening for LTBI in pediatric populations
remains the current recommendation of CDC and AAP, cli-
nician nonadherence to these guidelines results in overtest-
ing children at low risk for LTBI and undertesting children
at high risk for LTBI. In addition, the logistic issues with
targeted screening programs are important. Public health
measures must identify but not discriminate against high-
risk populations. However, in practice, pediatric healthcare
providers will continue to have a key role in identifying
children at risk for LTBI. Thus, they should be familiar
with risk factors for LTBI and screen children with TST
only when >1 risk factor is present. 
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